“…Viral preparations from EBV-positive Akata cells stimulated with anti-immunoglobulin G (anti-IgG) antibodies, IgG-stimulated EBV-negative Akata cells (mock controls), EBV-positive AGS cells stimulated with PMA, and PMA-stimulated EBV-negative AGS cells (mock controls) were produced as described previously (9,24). In selected experiments, EBV virions were inactivated by heating (1 h, 60°C) (8,36) or by exposure to UV (1 h, 265 nm) (3) prior to cell treatment. The specificity of the EBV response was evaluated by pretreatment of viral preparations with the neutralizing monoclonal antibody 72A1 (ATCC, Manassas, VA) raised against the viral envelope gp350/220 of EBV as described previously (23).…”